GB9718487D0 - Pulmonary hypertension - Google Patents

Pulmonary hypertension

Info

Publication number
GB9718487D0
GB9718487D0 GBGB9718487.3A GB9718487A GB9718487D0 GB 9718487 D0 GB9718487 D0 GB 9718487D0 GB 9718487 A GB9718487 A GB 9718487A GB 9718487 D0 GB9718487 D0 GB 9718487D0
Authority
GB
United Kingdom
Prior art keywords
pulmonary hypertension
hypertension
pulmonary
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9718487.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Sheffield
Original Assignee
University of Sheffield
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Sheffield filed Critical University of Sheffield
Priority to GBGB9718487.3A priority Critical patent/GB9718487D0/en
Publication of GB9718487D0 publication Critical patent/GB9718487D0/en
Priority to EP98940410A priority patent/EP1009822A1/en
Priority to CA002302167A priority patent/CA2302167A1/en
Priority to AU88741/98A priority patent/AU8874198A/en
Priority to JP2000508789A priority patent/JP2001515011A/en
Priority to PCT/GB1998/002584 priority patent/WO1999011778A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1136—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against growth factors, growth regulators, cytokines, lymphokines or hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB9718487.3A 1997-09-02 1997-09-02 Pulmonary hypertension Ceased GB9718487D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GBGB9718487.3A GB9718487D0 (en) 1997-09-02 1997-09-02 Pulmonary hypertension
EP98940410A EP1009822A1 (en) 1997-09-02 1998-09-02 Antisense treatment of pulmonary hypertension
CA002302167A CA2302167A1 (en) 1997-09-02 1998-09-02 Antisense treatment of pulmonary hypertension
AU88741/98A AU8874198A (en) 1997-09-02 1998-09-02 Antisense treatment of pulmonary hypertension
JP2000508789A JP2001515011A (en) 1997-09-02 1998-09-02 Antisense treatment for pulmonary hypertension
PCT/GB1998/002584 WO1999011778A1 (en) 1997-09-02 1998-09-02 Antisense treatment of pulmonary hypertension

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9718487.3A GB9718487D0 (en) 1997-09-02 1997-09-02 Pulmonary hypertension

Publications (1)

Publication Number Publication Date
GB9718487D0 true GB9718487D0 (en) 1997-11-05

Family

ID=10818333

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9718487.3A Ceased GB9718487D0 (en) 1997-09-02 1997-09-02 Pulmonary hypertension

Country Status (6)

Country Link
EP (1) EP1009822A1 (en)
JP (1) JP2001515011A (en)
AU (1) AU8874198A (en)
CA (1) CA2302167A1 (en)
GB (1) GB9718487D0 (en)
WO (1) WO1999011778A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999060166A1 (en) * 1998-05-21 1999-11-25 Isis Pharmaceuticals, Inc. Compositions and methods for the pulmonary delivery of nucleic acids
AU4007899A (en) * 1998-05-21 1999-12-06 Isis Pharmaceuticals, Inc. Compositions and methods for the pulmonary delivery of nucleic acids
US6087343A (en) * 1998-09-14 2000-07-11 University Of Florida Antisense oligonucleotides targeted to β-1 adrenoceptor and methods of use
ATE377645T1 (en) * 1999-03-18 2007-11-15 Queen Mary & Westfield College INHIBITORS OF ENDOTHELIN-1 SYNTHESIS
AU2001289861A1 (en) * 2000-09-19 2002-04-02 Epidauros Biotechnologie Ag Polymorphisms in human genes of cardiovascular regulators and their use in diagnostic and therapeutic applications
WO2016083624A1 (en) * 2014-11-28 2016-06-02 Silence Therapeutics Gmbh Means for inhibiting the expression of edn1

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2279014B (en) * 1993-06-02 1997-07-16 Niall Keaney Device for controlling delivery of respiratory drugs
GB9320978D0 (en) * 1993-10-12 1993-12-01 Higenbottam Timohy W Nitric oxide treatment
US5994315A (en) * 1995-06-07 1999-11-30 East Carolina University Low adenosine agent, composition, kit and method for treatment of airway disease
GB2320900B (en) * 1997-01-07 2000-08-30 Univ Sheffield Inhalers

Also Published As

Publication number Publication date
EP1009822A1 (en) 2000-06-21
CA2302167A1 (en) 1999-03-11
WO1999011778B1 (en) 1999-04-15
AU8874198A (en) 1999-03-22
WO1999011778A1 (en) 1999-03-11
JP2001515011A (en) 2001-09-18

Similar Documents

Publication Publication Date Title
PL335999A1 (en) Substituted 3-cyanoquinolines
AP2000001795A0 (en) Substituted 4-aminothiazol-2-yol
EP1022970A4 (en) Playyard
IL135343A0 (en) Novel aryloxy-alkyl-dialkylamines
SI1036083T1 (en) Novel 9a-azalides
GB9705787D0 (en) Modified dendroaspins
HU9800057D0 (en) Bust-supporter
DE69727985D1 (en) Extravasationserkennungsvorrichtung
ZA9810184B (en) New phenyl-alkyl-imidazoles
GB9712536D0 (en) Disc-retainer
GB9718487D0 (en) Pulmonary hypertension
DE69729893D1 (en) Druckbläter
EP1001981A4 (en) Heregulin-like factor
IL130600A0 (en) Substituted 4-benzoyl-pyrazole
GB2329418B (en) Stays
GB2331123B (en) Stays
GB9720096D0 (en) Stays
ZA985761B (en) Substituted aryluracils
IL133261A0 (en) Substituted naphthropyrans
GB9823636D0 (en) Wedge
PL318601A1 (en) Novel 5-arylidene-4-oxo-2-imidazpglycines
GB2330622B (en) Stays
CA81080S (en) Shingle
GB9722452D0 (en) Stays
GB9724596D0 (en) Wedge

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)